Pimozide Tablet Market To Witness 9.5% CAGR Growth Through 2030: Key Industry Drivers
Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.
#Pimozide Tablet Market Growth Analysis: How Will Revenue Trend Over The Forecast Period?#_x000D_
The pimozide tablet market size has experienced significant expansion in recent years. It is anticipated to expand from $1.84 billion in 2025 to $2.02 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 9.9%. Historically, this growth can be ascribed to a scarcity of treatment options for Tourette’s syndrome, a rise in the prevalence of chronic schizophrenia, an expansion in hospital and clinic infrastructure, increased awareness of antipsychotic therapies, and a continued dependence on traditional offline pharmacies._x000D_
_x000D_
The pimozide tablet market is projected to undergo significant expansion in the coming years, with an anticipated increase to $2.91 billion by 2030, reflecting a compound annual growth rate (CAGR) of 9.5%. This projected growth stems from factors such as the development of low-dose and unit-dose pimozide tablets, the proliferation of online pharmacy platforms, the growing adoption of home healthcare services, an increase in government initiatives for mental health, and the integration of digital tools for adherence monitoring. Important trends anticipated during this period include enhanced awareness of Tourette’s syndrome and chronic schizophrenia, a rising preference for oral antipsychotic medications, an increase in home-based mental health care and therapy, the expansion of online pharmaceutical distribution channels, and the innovation of personalized dosing and packaging options._x000D_
_x000D_
#Get A Free Sample Report With In-Depth Market Insights:#_x000D_
_x000D_
#Pimozide Tablet Market Expansion Drivers: What’s Shaping Future Growth?#_x000D_
The increasing occurrence of psychiatric disorders is anticipated to fuel the expansion of the pimozide tablet market going forward. These are mental health issues marked by considerable disruptions in thinking, feeling, or actions, resulting in distress or impaired abilities. The growing incidence of psychiatric disorders is largely due to factors such as elevated stress levels, evolving societal standards, improved recognition and diagnosis, and inherited susceptibilities. Pimozide tablets address symptoms like delusions and tics in psychiatric disorders by obstructing dopamine receptors, thereby assisting in the reduction of irregular brain activity. For instance, data from August 2025 by the Substance Abuse and Mental Health Services Administration (SAMHSA), a US-based federal agency, indicated that 23.4% of adults aged 18 or older (approximately 61.5 million people) suffered from any mental illness (AMI), with around 5.6 % reporting a serious mental illness (SMI). In comparison, 22.8 % (58.7 million people) and 5.7 % (14.6 million people) of adults reported AMI and SMI, respectively, in 2023. Consequently, the increasing occurrence of psychiatric disorders is propelling the pimozide tablet market._x000D_
_x000D_
#Pimozide Tablet Market Breakdown By Product Type And Application#_x000D_
The pimozide tablet market covered in this report is segmented – _x000D_
_x000D_
1) By Type: 1 Milligram, 2 Milligram, 4 Milligram_x000D_
2) By Distribution Channel: Online, Offline_x000D_
3) By Application: Tourette’s Syndrome, Chronic Schizophrenia_x000D_
4) By End User: Hospitals, Clinics, Home Use_x000D_
_x000D_
_x000D_
_x000D_
_x000D_
#Pimozide Tablet Market Company Landscape And Competitive Strategy#_x000D_
Major companies operating in the pimozide tablet market are Pfizer Inc., Johnson & Johnson, AbbVie Inc., Novartis AG, Bristol-Myers Squibb, GlaxoSmithKline plc, C.H. Boehringer Sohn AG & Co. KG, Teva Pharmaceutical Industries Ltd., Hetero Drugs, Sun Pharmaceutical Industries Ltd., Jazz Pharmaceuticals, Aurobindo Pharma, Cipla Limited, Apotex Inc., H. Lundbeck A/S, Dr. Reddy’s Laboratories, Hikma Pharmaceuticals, Amneal Pharmaceuticals, Endo International, Lupin Limited, Zydus Cadila, Alkem Laboratories, Torrent Pharmaceuticals, Glenmark Pharmaceuticals, Mallinckrodt Pharmaceuticals, Jubilant Life Sciences, Alembic Pharmaceuticals, Wockhardt, AA Pharma, Taj Pharmaceuticals _x000D_
_x000D_
#View The Full Pimozide Tablet Market Report:#_x000D_
_x000D_
#Pimozide Tablet Market Geographic Landscape: Which Region Dominates Industry Growth?#_x000D_
North America was the largest region in the pimozide tablet market in 2025. The regions covered in the pimozide tablet market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_
_x000D_
#Reach Out To Our Team:#_x000D_
_x000D_
The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_
Americas: +1 310-496-7795_x000D_
Asia: +44 7882 955267 & +91 8897263534_x000D_
Europe: +44 7882 955267_x000D_
Email us at: marketing@tbrc.info_x000D_
_x000D_
#Follow us on:#_x000D_
_x000D_
LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
